Amiodarone-induced thyrotoxicosis

被引：6
|
作者：
Schubert, Louis [1 ]
Bricaire, Leopoldine [1 ]
Groussin, Lionel [1 ,2 ,3 ]
机构：
[1] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France
[2] Univ Paris, F-75014 Paris, France
[3] Inst Cochin, Inserm Unite 1016, CNRS UMR 8104, F-75014 Paris, France
来源：
ANNALES D ENDOCRINOLOGIE | 2021年 / 82卷 / 3-4期
关键词：
Amiodarone; Thyrotoxicosis; Hyperthyroidism; ASSOCIATION; GUIDELINES; MANAGEMENT; TYPE-2; THYROIDECTOMY; CONTINUATION; THERAPY;
D O I：
10.1016/j.ando.2020.04.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：163 / 166
页数：4
相关论文
共 50 条
  • [41] Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies
    Cardenas, GA
    Cabral, JM
    Leslie, CA
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2003, 70 (07) : 624 - +
  • [42] Is amiodarone-induced thyrotoxicosis associated with increased mortality?
    Elizabeth N Pearce
    Lewis E Braverman
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 668 - 669
  • [43] Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism
    Hofmann, Andrea
    Nawara, Clemens
    Ofluoglu, Sedat
    Holzmannhofer, Johannes
    Strohmer, Bernhard
    Pirich, Christian
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (15-16) : 493 - 498
  • [44] Clinical review 120 - Amiodarone-induced thyrotoxicosis
    Daniels, GH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01): : 3 - 8
  • [45] Amiodarone-induced thyrotoxicosis, an overview of UK management
    Raghavan, Rajeev P.
    Taylor, Peter N.
    Bhake, Ragini
    Vaidya, Bijay
    Martino, Enio
    Bartalena, Luigi
    Dayan, Colin M.
    Bradley, Karin
    CLINICAL ENDOCRINOLOGY, 2012, 77 (06) : 936 - 937
  • [46] Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis
    Czarnywojtek, A.
    Czepczynski, R.
    Ruchala, M.
    Zgorzalewicz-Stachowiak, M.
    Szczepanek, E.
    Zamyslowska, H.
    Bartkowiak, Z.
    Sowinski, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S445 - S445
  • [47] Anesthetic Considerations in a Patient with Amiodarone-Induced Thyrotoxicosis
    Calis, Paul
    Berendsen, Remco
    Logeman, Angelique
    Sarton, Elise
    Aarts, Leon
    CASE REPORTS IN MEDICINE, 2010, 2010
  • [48] AMIODARONE-INDUCED THYROTOXICOSIS SUGGESTIVE OF THYROID DAMAGE
    LAMBERT, M
    UNGER, J
    DENAYER, P
    BROHET, C
    GANGJI, D
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1990, 13 (06) : 527 - 530
  • [49] A case of type 2 amiodarone-induced thyrotoxicosis
    Soloviuk, O. A.
    Kulynych, R. L.
    Soloviuk, O. O.
    ZAPOROZHYE MEDICAL JOURNAL, 2024, 26 (03) : 254 - 257
  • [50] Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis
    Woeber, KA
    Warner, I
    WESTERN JOURNAL OF MEDICINE, 1999, 170 (01): : 49 - 51
12345